Eric L. Nuermberger

Also affiliated with Johns Hopkins Medicine

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 37 papers. Top paper: “High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial”.

High-Dose Isoniazid Lacks EARLY Bactericidal Activity against Isoniazid-resistant Tuberculosis Mediated by katG Mutations: A Randomized Phase II Clinical Trial

American Journal of Respiratory and Critical Care Medicine(2024)10.1164/rccm.202311-2004oc

N/A

0.741DataRank · unranked

13 citations

Elisa H. Ignatius, Veronique de Jager, Caryn M. Upton, Soyeon Kim, Ashley McKhann +14 more

Predicting nitroimidazole antibiotic resistance mutations in Mycobacterium tuberculosis with protein engineering

PLoS Pathogens(2020)10.1371/journal.ppat.1008287

N/A

0.666DataRank · unranked

84 citations

Liam K. Harold, Deepak V. Almeida, Livnat Afriat‐Jurnou, Htin Aung, Brian M. Forde +13 more

Combination of Mycobacterium tuberculosis RS Ratio and CFU Improves the Ability of Murine Efficacy Experiments to Distinguish between Drug Treatments

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.02310-21

N/A

0.494DataRank · unranked

26 citations

Allison Bauman, Michelle E. Ramey, Karen Rossmassler, Reem Al Mubarak, Samantha Pauly +10 more

ACTG A5409 (RAD-TB): Study protocol for a phase 2 randomized, adaptive, dose-ranging, open-label trial of novel regimens for the treatment of pulmonary tuberculosis

Trials(2025)10.1186/s13063-025-08973-w

N/A

0.168DataRank · unranked

2 citations

Gustavo E. Velásquez, Russell R. Kempker, Marjorie Z. Imperial, Eric L. Nuermberger, Susan E. Dorman +22 more

Pharmacodynamic Correlates of Linezolid Activity and Toxicity in Murine Models of Tuberculosis

The Journal of Infectious Diseases(2020)10.1093/infdis/jiaa016

N/A

0DataRank · unranked

25 citations

Amelia N. Deitchman, Si-Yang Li, Kala Barnes-Boyle, Sandeep Tyagi, Heena Soni +4 more

Preserved Efficacy and Reduced Toxicity with Intermittent Linezolid Dosing in Combination with Bedaquiline and Pretomanid in a Murine Tuberculosis Model

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01178-20

N/A

0DataRank · unranked

35 citations

Rokeya Tasneen, Yong S. Chang, Kelly E. Dooley, Eric L. Nuermberger, Kristina M. Bigelow

Telacebec for Ultrashort Treatment of Buruli Ulcer in a Mouse Model

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.00259-20

N/A

0DataRank · unranked

34 citations

Paul J. Converse, Till F. Omansen, Sandeep Tyagi, Rokeya Tasneen, Jeongjun Kim +2 more

Mutations in fbiD (Rv2983) as a novel determinant of resistance to pretomanid and delamanid in Mycobacterium tuberculosis

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.09.10.292508

N/A

0DataRank · unranked

1 citations

Si‐Yang Li, Thomas R. Ioerger, Keshav V. Shah, Jean‐Philippe Lanoix, Jin Lee +4 more

Preserved efficacy and reduced toxicity with intermittent linezolid dosing in combination with bedaquiline and pretomanid in a murine TB model

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.06.10.145334

N/A

0DataRank · unranked

0 citations

Rokeya Tasneen, Yong S. Chang, Kelly E. Dooley, Eric L. Nuermberger, Kristina M. Bigelow

Differential in vitro activity of individual drugs and bedaquiline-rifabutin combinations against actively multiplying and nutrient-starved Mycobacterium abscessus

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.10.14.340422

N/A

0DataRank · unranked

0 citations

Nicole C. Ammerman, Anusha Agarwal, Maram Naji, Si‐Yang Li, Eric L. Nuermberger +1 more

Small animal models for human immunodeficiency virus (HIV), hepatitis b, and tuberculosis: Proceedings of an NIAID workshop

UNC Libraries(2020)10.17615/v9jq-m080

N/A

0DataRank · unranked

0 citations

Alexander Ploß, Eric L. Nuermberger, Karl‐Dimiter Bissig, Brigitte E. Sanders-Beer, Brent E. Korba +15 more

Impact of Dose, Duration, and Immune Status on Efficacy of Ultrashort Telacebec Regimens in Mouse Models of Buruli Ulcer

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01418-21

N/A

0DataRank · unranked

17 citations

Deepak V. Almeida, Paul J. Converse, Till F. Omansen, Eric L. Nuermberger, Oliver Komm

In Vitro Activity of Bedaquiline and Imipenem against Actively Growing, Nutrient-Starved, and Intracellular Mycobacterium abscessus

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01545-21

N/A

0DataRank · unranked

9 citations

Jin Lee, Amit Kaushik, Nicole C. Ammerman, Kelly E. Dooley, Eric L. Nuermberger +1 more

Comparative Efficacy of Rifapentine Alone and in Combination with Isoniazid for Latent Tuberculosis Infection: a Translational Pharmacokinetic-Pharmacodynamic Modeling Study

Antimicrobial Agents and Chemotherapy(2021)10.1128/aac.01705-21

N/A

0DataRank · unranked

6 citations

Jacqueline P. Ernest, Nan Zhang, Nicole C. Ammerman, Eric L. Nuermberger, Robert Belknap +4 more

Impact of dose, duration and host immune status on ultrashort telacebec treatment in a mouse model of Buruli ulcer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.22.449541

N/A

0DataRank · unranked

0 citations

Paul J. Converse, Oliver Komm, Eric L. Nuermberger, Deepak V. Almeida

Ultrashort treatment with telacebec alone and with companion drugs in immunocompetent and immunosuppressed mouse footpad models of Buruli ulcer

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.22.449542

N/A

0DataRank · unranked

0 citations

Deepak V. Almeida, Paul J. Converse, Till F. Omansen, Eric L. Nuermberger, Oliver Komm

In vitro activity of bedaquiline and imipenem against actively growing, nutrient-starved, and intracellular Mycobacterium abscessus

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.08.06.455495

N/A

0DataRank · unranked

0 citations

Jin Lee, Amit Kaushik, Nicole C. Ammerman, Kelly E. Dooley, Eric L. Nuermberger +1 more

Lysyl-tRNA synthetase, a target for urgently needed M. tuberculosis drugs

Nature Communications(2022)10.1038/s41467-022-33736-5

N/A

0DataRank · unranked

34 citations

Susan H. Davis, Sebastian Damerow, Curtis A. Engelhart, Michael Mathieson, Beatriz Baragaña +40 more

T405, a New Penem, Exhibits In Vivo Efficacy against M. abscessus and Synergy with β-Lactams Imipenem and Cefditoren

Antimicrobial Agents and Chemotherapy(2022)10.1128/aac.00536-22

N/A

0DataRank · unranked

18 citations

Hunter R. Batchelder, Elizabeth Story‐Roller, Chandra M. Panthi, Chavis Tabor, Eric L. Nuermberger +3 more

The Novel Oxazolidinone TBI-223 Is Effective in Three Preclinical Mouse Models of Methicillin-Resistant Staphylococcus aureus Infection

Microbiology Spectrum(2022)10.1128/spectrum.02451-21

N/A

0DataRank · unranked

15 citations

Dustin Dikeman, Roger V. Ortines, Yu Wang, Christine Youn, Mohammed Mumtaz +11 more

Potential Impact of Long-Acting Products on the Control of Tuberculosis: Preclinical Advancements and Translational Tools in Preventive Treatment

Clinical Infectious Diseases(2022)10.1093/cid/ciac672

N/A

0DataRank · unranked

9 citations

Eric L. Nuermberger, Andrew Owen, Steve P. Rannard, Caren L. Freel Meyers, Susan Swindells +1 more

Structure–Activity Relationship of Penem Antibiotic Side Chains Used against Mycobacteria Reveals Highly Active Compounds

ACS Infectious Diseases(2022)10.1021/acsinfecdis.2c00229

N/A

0DataRank · unranked

9 citations

Trevor A. Zandi, Amit Kaushik, Akul Naik, Elizabeth Story‐Roller, Emily C. Maggioncalda +4 more

GSK2556286 is a novel antitubercular drug candidate effective in vivo with the potential to shorten tuberculosis treatment

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.02.04.479214

N/A

0DataRank · unranked

11 citations

Maria Santos Martínez, Olalla Sanz, Beatriz Urones, Jorge Esquivias, Heena Soni +25 more

Discovery of natural-product-derived sequanamycins as potent oral anti-tuberculosis agents

Cell(2023)10.1016/j.cell.2023.01.043

N/A

0DataRank · unranked

24 citations

Christine Lair, Christine Roubert, Kwame Amaning, María Belén Pascual Barrio, Yannick Benedetti +26 more

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

European Respiratory Journal(2023)10.1183/13993003.00165-2023

N/A

0DataRank · unranked

16 citations

Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob C. van Wijk, Nan Zhang +4 more

Long-term effects of prenatal arsenic exposure from gestational day 9 to birth on lung, heart, and immune outcomes in the C57BL/6 mouse model

Toxicology Letters(2023)10.1016/j.toxlet.2023.05.011

N/A

0DataRank · unranked

6 citations

Emily Illingworth, Ian F. Sanchez, Sarah E. Attreed, Prithvi Sinha, Kevin M. Casin +9 more

The Many Hosts of Mycobacteria 9 (MHM9): A conference report

Tuberculosis(2023)10.1016/j.tube.2023.102377

N/A

0DataRank · unranked

5 citations

Kathleen A. Alexander, Deepak V. Almeida, Matthew Z. Anderson, Ray L. Ball, Gillian Beamer +56 more

Using Dynamic Oral Dosing of Rifapentine and Rifabutin to Simulate Exposure Profiles of Long-Acting Formulations in a Mouse Model of Tuberculosis Preventive Therapy

Antimicrobial Agents and Chemotherapy(2023)10.1128/aac.00481-23

N/A

0DataRank · unranked

2 citations

Si‐Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steve P. Rannard +4 more

Translational predictions of phase 2a first-in-patient efficacy studies for antituberculosis drugs

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.01.18.524608

N/A

0DataRank · unranked

2 citations

Janice Jia Ni Goh, Natasha Strydom, Qianwen Wang, Rob C. van Wijk, Nan Zhang +4 more

Using dynamic oral dosing of rifapentine and rifabutin to simulate exposure profiles of long-acting formulations in a mouse model of tuberculosis preventive therapy

bioRxiv (Cold Spring Harbor Laboratory)(2023)10.1101/2023.04.12.536604

N/A

0DataRank · unranked

0 citations

Si‐Yang Li, Henry Pertinez, Fabrice Betoudji, Jin Lee, Steve P. Rannard +4 more

Hyaluronidase impacts exposures of long-acting injectable paliperidone palmitate in rodent models

bioRxiv (Cold Spring Harbor Laboratory)(2024)10.1101/2024.03.03.583160

N/A

0DataRank · unranked

2 citations

Amit Kaushik, Paul Curley, Usman Arshad, Eman El‐Khateeb, Si‐Yang Li +11 more

Predicting tuberculosis drug efficacy in preclinical and clinical models from in vitro data

iScience(2025)10.1016/j.isci.2025.111932

N/A

0DataRank · unranked

4 citations

Anu Patel, Bernard Ngara, Rob C. van Wijk, Natasha Strydom, Qianwen Wang +9 more

Mutations in fbiD ( Rv2983 ) as a Novel Determinant of Resistance to Pretomanid and Delamanid in Mycobacterium tuberculosis

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01948-20

N/A

0DataRank · unranked

88 citations

Si-Yang Li, Thomas R. Ioerger, Keshav V. Shah, Jean‐Philippe Lanoix, Jin Lee +4 more

Translational Modeling of BTZ-043 to Predict Phase 2A Efficacy and Evaluate Drug-Drug Interactions With Bedaquiline, Pretomanid, and Linezolid in Murine Models

The Journal of Infectious Diseases(2025)10.1093/infdis/jiaf088

N/A

0DataRank · unranked

1 citations

Lorenzo Flori, Rob C. van Wijk, Jacqueline P. Ernest, Sandeep Tyagi, Heena Soni +7 more

Mechanistic Modeling of Mycobacterium tuberculosis Infection in Murine Models for Drug and Vaccine Efficacy Studies

Antimicrobial Agents and Chemotherapy(2020)10.1128/aac.01727-19

N/A

0DataRank · unranked

32 citations

Natasha Strydom, Sandeep Tyagi, Heena Soni, Rokeya Tasneen, Eric L. Nuermberger +2 more

Development of New Tuberculosis Drugs: Translation to Regimen Composition for Drug-Sensitive and Multidrug-Resistant Tuberculosis

The Annual Review of Pharmacology and Toxicology(2020)10.1146/annurev-pharmtox-030920-011143

N/A

0DataRank · unranked

48 citations

Natasha Strydom, Qianwen Wang, Nan Zhang, Eric L. Nuermberger, Véronique Dartois +2 more

Development of a penem antibiotic against Mycobacteroides abscessus

Communications Biology(2020)10.1038/s42003-020-01475-2

N/A

0DataRank · unranked

19 citations

Elizabeth Story‐Roller, Evan P. Lloyd, Amit Kaushik, Kristina M. Bigelow, Emily C. Maggioncalda +4 more